3 results about "Chronic glomerulonephritis" patented technology

The invention discloses a medicinal moxa composition for preventing and treating codiseases of beriberi and chronic glomerulonephritis. The medicinal moxa composition is prepared from radix aconiti carmichaeli, cortex cinnamomi, cornu cervi pantotrichum, rhizoma alismatis, radix achyranthis bidentatae and moxa. The medicinal moxa composition disclosed by the invention has remarkable external antibacterial and warming effects, consists of five yang warming medicines and one warming medicine, releases volatile components through combustion, and stimulates acupuncture points in combination with heating power, so that the dual effects of treating beriberi and chronic glomerulonephritis are achieved. The radix aconiti carmichaeli, cinnamon, cornu cervi pantotrichum, rhizoma alismatis, radix achyranthis bidentatae and wormwood in the formula form a unique synergistic effect mechanism in the external use process, so that the medicinal components directly reach the focus through skin penetration, and meanwhile, the qi and blood of the whole body are regulated. Through infrared radiation, volatile antibacterial components and a warming effect generated by combustion of the medicinal moxa, the dual treatment effects of external warming and dredging and internal qi and blood regulation are achieved, and a new thought is provided for treatment of foot fungal infection and kidney meridian dysfunction.

The invention discloses a traditional Chinese medicine ointment formula for treating kidney deficiency and damp-heat syndrome type chronic glomerulonephritis as well as a preparation method and application thereof. The ointment formula is prepared from astragalus membranaceus, codonopsis pilosula, bighead atractylodes rhizome, donkey-hide gelatin, radix aconiti lateralis preparata, semen cuscutae, eucommia ulmoides, the root of kudzu vine, dried ginger, medicated leaven, rhizoma polygonati, gynostemma pentaphylla, teasel root, lucid ganoderma, divaricate saposhnikovia root, ligusticum wallichii, the root of bidentate achyranthes, parasitic loranthus, deer-horn glue, angelica sinensis, pulp of dogwood fruit, caulis spatholobi, gastrodia elata and pyrrosia lingua. According to the pathogenesis characteristics of the chronic glomerulonephritis, according to clinical practice, treatment based on syndrome differentiation, emphasis on tongue vein change, emphasis on combination of four diagnoses, mastering of yin and yang, and taking flat as a period; five internal organs are harmonized, and spleen and kidney are used as the basis; warm and clear effects are combined, and dynamic and static effects are combined; clinical test results show that after the ointment provided by the invention is used for treatment, the improvement condition of a treatment group is obviously superior to that of a control group, and the total effective rates of the treatment group and the control group in the treatment effect of the traditional Chinese medicine syndromes are 93.3% and 46.7% respectively; therefore, the ointment has a remarkable curative effect in the aspect of relieving the traditional Chinese medicine syndromes of the patients with the kidney-deficiency damp-heat syndrome type chronic nephritis.

To provide an ATP production promoter useful for preventing or treating diseases associated with decreased ATP production, particularly renal impairment. [Solution] The present invention comprises an ATP production promoter containing a component having URAT1 inhibitory activity. Preferably, the component having URAT1 inhibitory activity is at least one selected from the group consisting of benzbromarone, probenecid, dotinurad, recinurad, and berinurad. The present invention is expected to be useful as a preventive and therapeutic agent for diseases of decreased ATP production, and is particularly useful as a therapeutic and / or preventive agent for nephrotic syndrome, chronic glomerulonephritis, chronic tubulointerstitial nephritis, chronic pyelonephritis, amyloid kidney, familial juvenile hyperuricemia nephropathy, autosomal dominant tubulointerstitial kidney disease, nephronoplasia, renovascular hypertension, renal vein thrombosis, renal arteriovenous fistula, renal tubular acidosis, Gitelman syndrome, Bartter syndrome, Fanconi syndrome, Lowe syndrome, Alport syndrome, kidney and ureteral stones, and chronic renal failure.